Bafna Pharmaceuticals to raise funds from various routes

27 Nov 2013 Evaluate

Bafna Pharmaceuticals is looking to raise funds from various routes and is also in early stages of negotiations. Separately, the US-based generic drug maker Mylan Inc and two Indian pharma companies are reportedly in the race to acquire this Chennai-based Company.

Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.

Bafna Pharma Share Price

87.30 0.00 (0.00%)
16-Apr-2024 16:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1538.65
Dr. Reddys Lab 6081.25
Cipla 1375.65
Zydus Lifesciences 945.50
Lupin 1624.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.